Skip to content
healthcare.dev
Get a free key

Varubi

NDC 87628-101, rolapitant, tablet, from Luria Therapeutics LLC.

Product NDC
87628-101
Status
Listed
Labeler
Luria Therapeutics LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206500
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87628-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROLAPITANT HYDROCHLORIDE90 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
87628-101-02876280101022 TABLET in 1 BLISTER PACK (87628-101-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8670c3cf-82d9-466d-be49-de33d8c8742b

Use it

Look up 87628-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87628-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87628-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.